On June 17, 2025, telehealth startup Ulo unveiled its new service aimed at addressing a growing health concern for men—low testosterone. The service, which offers a personalized approach to Testosterone Replacement Therapy (TRT), promises an innovative, at-home alternative to the traditional, in-person healthcare model. By providing men with convenient access to blood tests, consultations with licensed doctors, and customized treatment plans, Ulo is setting a new standard for proactive healthcare in a field long underserved by traditional medical practices.
The rise of telehealth has transformed how people access medical care, particularly for ongoing treatments or consultations that do not require in-person visits. With its TRT offering, Ulo capitalizes on this shift, giving men who are experiencing symptoms of low testosterone, such as fatigue, decreased libido, and mood swings, the ability to receive effective treatment in the comfort of their own homes. The company, co-founded by Deep Patel and Rob English, seeks to reduce the barriers to treatment, such as the inconvenience of frequent doctor visits and the high cost of healthcare, by offering a convenient monthly subscription service priced at $159.
The decision to offer at-home testing and consultations is particularly timely. Testosterone levels in men have been steadily declining over the past few decades, a trend that has raised concerns among medical professionals. The condition, often referred to as “low T,” is linked to a variety of health problems, including cardiovascular issues, weight gain, and mental health challenges. However, despite its growing prevalence, low testosterone remains underdiagnosed and under-treated, partially due to the social stigma surrounding male health concerns and a general lack of awareness. Ulo is working to address this gap by bringing attention to what its co-founder Patel calls a “silent epidemic.”
Through Ulo’s telehealth platform, men can start their TRT journey with a simple at-home blood test, which is sent directly to the customer’s home. The test measures testosterone levels and helps to identify if the individual is indeed suffering from low testosterone, which often goes unnoticed until symptoms become more pronounced. Based on the results, a licensed healthcare professional conducts a virtual consultation to discuss treatment options. These options can include testosterone injections, creams, and gels, with the most appropriate treatment determined according to the patient’s needs and preferences.
The company emphasizes safety and personalized care throughout the process. Ulo’s approach includes regular lab assessments to monitor the treatment’s effectiveness and ensure that testosterone levels remain within safe ranges. Moreover, for men who are concerned about the impact of TRT on their fertility, Ulo provides fertility preservation options, allowing patients to explore ways to maintain their ability to father children while undergoing therapy. These added benefits align with Ulo’s commitment to a holistic, patient-centered approach that prioritizes both health and quality of life.
One of the defining features of Ulo’s model is its decision to operate independently of insurance. This decision is rooted in the founders’ belief that the traditional healthcare system does not prioritize proactive care. According to Patel, the primary goal of Ulo is to provide accessible, high-quality healthcare that empowers men to take control of their health without the bureaucratic red tape that often accompanies insurance-based care. This approach also means that patients do not have to wait for insurance approval or deal with the complexity of navigating different health plans, giving them faster and more direct access to necessary treatments.
In the broader context, Ulo’s launch of its at-home testosterone therapy service reflects a growing trend toward personalized medicine. As more patients seek treatment that is tailored to their unique needs and lifestyles, companies like Ulo are stepping in to meet that demand. The startup’s commitment to proactive healthcare is especially relevant in an age where chronic conditions, including low testosterone, are becoming more common among men of all ages. As more men seek to address health issues before they develop into more serious concerns, Ulo’s innovative model could be a game-changer in the telehealth space.
The service is also likely to resonate with younger men who are more comfortable with telehealth and are seeking treatments that fit into their busy lives. In recent years, men in their 30s and 40s have increasingly turned to testosterone replacement as a way to mitigate the effects of aging, a growing awareness that may contribute to Ulo’s success in this niche market.
Ultimately, Ulo’s launch highlights the importance of tackling health issues that often go unaddressed. By focusing on low testosterone, a condition that many men are reluctant to seek help for, Ulo is not only making treatment more accessible but also breaking down the stigma around male health. With the success of telehealth services continuing to grow, Ulo’s model may inspire other startups to follow suit and develop similar solutions for underserved medical needs.
As awareness of low testosterone continues to rise, Ulo’s launch provides a crucial opportunity for men to take charge of their health with the convenience of home-based care. Whether through blood tests, consultations, or ongoing treatment plans, Ulo offers a comprehensive service that could significantly change how men approach their health and well-being.